In compliance with Regulation 13 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Bio-Tech (India) has informed about quarterly statement of Investor Complaints as per Regulation 13 (3) Of SEBI (LODR) Regulation, 2015.
The above information is a part of company’s filings submitted to BSE.